Discrepancy between clinical and pathologic stage: impact on prognosis after radical cystectomy.

[1]  M. Stöckle,et al.  Complete long‐term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer , 2006, BJU international.

[2]  R. Hautmann,et al.  Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. , 2005, The Journal of urology.

[3]  F. Liedberg,et al.  Lymph node metastasis in bladder cancer. , 2006, European urology.

[4]  R. Kuefer,et al.  Effect of a pT0 cystectomy specimen without neoadjuvant therapy on survival , 2005, Cancer.

[5]  Joseph A. Smith.  Surgical treatment of bladder carcinoma , 2005, Cancer.

[6]  John T. Wei,et al.  Identifying risk factors for potentially avoidable complications following radical cystectomy. , 2005, The Journal of urology.

[7]  L. Mortelmans,et al.  FDG-PET for preoperative staging of bladder cancer , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[8]  C. Vale.  Neoadjuvant Chemotherapy in Invasive Bladder Cancer: Update of a Systematic Review and Meta-Analysis of Individual Patient Data: Advanced Bladder Cancer (ABC) Meta-analysis Collaboration , 2005 .

[9]  John T. Wei,et al.  The effects of stage divergence on survival after radical cystectomy for urothelial cancer. , 2005, Urologic oncology.

[10]  M. Taupitz,et al.  Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging. , 2004, Radiology.

[11]  M. Ghoneim,et al.  Lymphadenectomy with cystectomy: is it necessary and what is its extent? , 2004, European urology.

[12]  H. Grossman,et al.  Surgical factors influence bladder cancer outcomes: a cooperative group report. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  D. Grignon,et al.  Management of clinical T1 bladder transitional cell carcinoma by radical cystectomy. , 2004, Urologic oncology.

[14]  Gerhard Jakse,et al.  A second-look TUR in T1 transitional cell carcinoma: why? , 2004, European urology.

[15]  B. Malavaud.  T1G3 bladder tumours: the case for radical cystectomy. , 2004, European urology.

[16]  Sam S. Chang,et al.  Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. , 2003, The Journal of urology.

[17]  M. Grimm,et al.  Effect of routine repeat transurethral resection for superficial bladder cancer: a long-term observational study. , 2003, The Journal of urology.

[18]  M. Peyromaure,et al.  The value of a second transurethral resection in evaluating patients with bladder tumours. , 2003, European urology.

[19]  W. Huang,et al.  An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. , 2003, The Journal of urology.

[20]  Michael Cookson,et al.  Clinical under staging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy. , 2001, The Journal of urology.

[21]  D. Theodorescu,et al.  Impact of second opinion pathology in the definitive management of patients with bladder carcinoma , 2001, Cancer.

[22]  G. Jakse,et al.  Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? , 2001, The Journal of urology.

[23]  S. Groshen,et al.  Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  J. Stein.  Indications for early cystectomy. , 2000, Seminars in urologic oncology.

[25]  M. Resnick,et al.  Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy. , 2000, The Journal of urology.

[26]  J. Cheville,et al.  Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens. , 2000, American journal of clinical pathology.

[27]  H. Herr,et al.  The value of a second transurethral resection in evaluating patients with bladder tumors. , 2000, The Journal of urology.

[28]  W. Fair,et al.  The treated natural history of high risk superficial bladder cancer: 15-year outcome. , 1997, The Journal of urology.

[29]  M. Sarosdy,et al.  The significance of central pathology review in clinical studies of transitional cell carcinoma in situ. , 1997, The Journal of urology.

[30]  H. Herr.  Routine CT scan in cystectomy patients: does it change management? , 1996, Urology.

[31]  S. Groshen,et al.  Radical cystectomy for high risk patients with superficial bladder cancer in the era of orthotopic urinary reconstruction , 1995, Cancer.

[32]  P. Bassi,et al.  Results of contemporary radical cystectomy for invasive bladder cancer: a clinicopathological study with an emphasis on the inadequacy of the tumor, nodes and metastases classification. , 1991, The Journal of urology.

[33]  S. Boyd,et al.  The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2) , 1990, The Journal of urology.

[34]  M. Boon,et al.  Analysis of the performance of pathologists in the grading of bladder tumors. , 1983, Human pathology.

[35]  V. F. Marshall.  The relation of the preoperative estimate to the pathologic demonstration of the extent of vesical neoplasms. , 1952, The Journal of urology.